2 Minute Medicine Rewind October 14, 2019
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial 1. Adjuvant FOLFOX ...
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial 1. Adjuvant FOLFOX ...
1. In a phase II trial of T3 resectable rectal cancer, adding bevacizumab to induction and neoadjuvant chemoradiation resulted in ...
Image: PD 1. Early enteral nutrition (EEN) resulted in shorter time to first defecation after rectal resection for cancer and ...
Image: PD/Navy 1. Patients with mesorectal invasion of more than 5mm and sacral-side involvement (seen on MRI) demonstrated higher rates ...
Image: PD 1. Older age, male sex, African American race and non-private insurance are risk factors for margin positivity following ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.